A Phase III, multicenter,open-label study of ribociclib vs. palbociclib in patients with advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer – HARMONIA trial
Read more about this trial →← Back to available clinical trials
A Phase III, multicenter,open-label study of ribociclib vs. palbociclib in patients with advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer – HARMONIA trial
Read more about this trial →